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The juvenile phase is characterized by continuously progressing physiological processes such as
growth and maturation, which are accompanied by transitions in gene expression. The contribution
of transcriptome dynamics to the establishment of juvenile properties remains unclear. Here, we
investigated alternative splicing (AS) events in postnatal growth and elucidated the landscape of
age-dependent alternative splicing (ADAS) in C57BL/6 mice. Our analysis of ADAS in the cerebral
cortex, cardiomyocytes, and hepatocytes revealed numerous juvenile-specific splicing isoforms that
shape the juvenile transcriptome, which in turn functions as a basis for the highly anabolic status of
juvenile cells.Mechanistically, the juvenile-expressed splicing factor Srsf7mediates ADAS, as exempli-
fied by switching from juvenile to adult forms of anabolism-associated genes Eif4a2 and Rbm7.
Suppression of Srsf7 results in ‘‘fast-forwarding’’ of this transcriptome transition, causing impaired
anabolism and growth in mice. Thus, juvenile-specific AS is indispensable for the anabolic state of
juveniles and differentiates juveniles from adults.1Molecular Neuroscience
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Organisms undergo age-dependent alterations in body size and function as they grow into adults. One of
themechanisms regulating this process is an age-dependent transition in gene expression that is regulated
at the transcriptional and post-transcriptional levels. Transcription is a process of mRNA synthesis
controlled quantitatively by factors such as RNA polymerases, transcription factors, and chromatin
modifiers. Transcription is also controlled qualitatively by the use of alternative transcription start sites
and alternative polyadenylation. The post-transcriptional processing includes alternative splicing (AS),
(de)stabilization, RNA modifications such as RNA methylation (Zhao et al., 2016), RNA editing, interaction
with RNA-binding protein (RBP, Anders et al., 2012) and microRNA, transportation, and
compartmentalization.
AS increases transcript diversity. Following the discovery of splicing (Berget et al., 1977; Chow et al., 1977),
AS was identified as a system that generated multiple variant mRNAs from one gene (Alt et al., 1980; Early
et al., 1980). This process enables a limited number of genes to generate more molecules. AS thus expands
the proteome (Nilsen and Graveley, 2010) and is relevant to evolution (Barbosa-Morais et al., 2012). AS
occurs in tissue-specific patterns (Blekhman et al., 2010; Ellis et al., 2012) and cell-type-specific patterns
(e.g., embryonic stem cells [Han et al., 2013; Salomonis et al., 2010]), suggesting its role in differentiating
cellular contexts. AS has broad biological implications in synapse formation (Ule et al., 2005), sex determi-
nation (Baker, 1989), the epithelial-mesenchymal transition (Warzecha et al., 2009), etc. AS is also impli-
cated in pathogenesis (Cieply and Carstens, 2015; Tazi et al., 2009) and cancer (Venables et al., 2009).
Despite the multifaceted nature of AS, its age dependency is not well understood. Here, we investigate
age-dependent alternative splicing (ADAS) in the context of postnatal organ growth in mice.
The postnatal growth phase is a process in which an animal incorporates nutrition for anabolism, thus
growing in size. In addition, the functions of the organs mature during the process of growing into an adult.
For example, the brain undergoes striking functional enhancement via functional plasticity (Hensch, 2005).
Thus, juvenile animals possess distinct physiological characteristics, which we call ‘‘juvenile properties’’
(Jam et al., 2018; Tano et al., 2019). Despite its particular physiological traits, the juvenile phase has not
been studied as rigorously as the fetal development or adult phases. Thus, to explore these juvenileiScience 23, 100929, March 27, 2020 ª 2020 The Author(s).
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properties, we previously performed a comprehensive transcriptome analysis in mice of different ages and
identified juvenility-associated genes (JAGs, Jam et al., 2018) and juvenility-associated long noncoding
RNAs (JALNCs, Tano et al., 2019) as molecular building blocks of juvenile properties. These analyses
revealed that the juvenile phase is characterized by a specific gene expression profile (hereafter, juvenile
transcriptome) quite distinct from that of adults.
Our analyses of the juvenile transcriptome identified AS as an important mechanism regulating juvenile
properties (Jam et al., 2018), although the details remained unaddressed. Here, we show that juveniles
undergo global AS in an age-dependent manner that shapes the juvenile transcriptome. AS is the differ-
ential removal of introns from pre-mRNA and is observed in 92%–94% of multi-exon genes (Pan et al.,
2008; Wang et al., 2008). Splicing is carried out in spliceosomes that consist of five small nuclear ribonucleo-
protein particles (snRNPs), U1, U2, U4/U6, and U5; these snRNPs are the major components of the spliceo-
some, and numerous auxiliary proteins are also present (Chen and Manley, 2009). Spliceosome assembly is
a highly dynamic process that starts with the binding of SR proteins to exonic splicing enhancer (ESE); these
proteins stabilize the interaction of the U1 snRNP to the 50 splicing site (50 ss) of the intron via base pairing
with snRNA1 (Long and Caceres, 2009). The SR proteins also recruit the U2AF complex and U2 snRNP to the
30 ss (Chen and Manley, 2009; Nilsen and Graveley, 2010). Further incorporation of the U4/U6–U5 tri-snRNP
leads to the formation of a complex that contains all subunits, followed by extensive conformational
changes, resulting in the formation of the catalytically active spliceosome.
The Srsf7 splicing factor belongs to the SR protein family, which is encoded by nine genes in humans: SRSF1
(chr17), SRSF2 (chr17), SRSF3 (chr6), SRSF4 (chr1), SRSF5 (chr14), SRSF6 (chr20), SRSF7 (chr2), SRSF9 (chr12),
SRSF11 (chr1, Shepard and Hertel, 2009). The SR splicing factors possess an N-terminal RNA-binding
domain (RBD) and a C-terminal RS domain that is enriched with arginine-serine dipeptides. The RS domain
mediates protein-protein interactions that are required for spliceosome assembly (Kohtz et al., 1994;
Wu and Maniatis, 1993). Srsf7 additionally possesses a zinc-affinity domain between the RBD and the RS
domain (Jeong, 2017). It was also reported that a binding location relative to the 50 ss affects the splicing
regulation function of Srsf7 (Erkelenz et al., 2013). Srsf7 transports herpes simplex virus 1mRNAs (Escudero-
Paunetto et al., 2010) and is involved in processing HIV-1 mRNA (Valente et al., 2009), but the biological
roles of Srsf7 remain largely unknown.
Here, we describe ADAS in postnatally growing mouse organs as a model and investigate a role for Srsf7 in
the regulation of ADAS. Our analysis provides a landscape for ADAS and clarifies a role for Srsf7 in ADAS
and the establishment of the juvenile transcriptome.RESULTS
Age-Dependent Alternative Splicing in Growing Organ Transcriptomes
To comprehensively address ADAS, we performed a transcriptome analysis with mouse organs and
analyzed AS events in a transcriptome-wide manner. We performed RNA sequencing (RNA-seq) analysis
with the cerebral cortex (CC) of C57BL/6N mice in the juvenile and adult phases. We utilized postnatal
day 1 (P1) and P14 as juvenile phases and P56 as an adult phase. We combined the data from the CC
with our previously publicized dataset of cardiomyocytes (CMs) and hepatocytes (Heps) from mice of juve-
nile (P1 and P7) and adult (P56) phases (Jam et al., 2018). We investigated AS events among the different
ages using the mixture-of-isoforms (MISO) model (Katz et al., 2010) and comprehensively identified AS
events that occurred in a phase-specific manner as ADAS events (Figure 1A). This analysis identified
numerous ADAS events, as examples, in Tpm2, Ndrg2, and Fn1 (Figure 1B). Tpm2 underwent exon skip-
ping in which an exon was included in a juvenile-specific manner (juvenile-exon inclusion). In contrast,
Ndrg2 underwent exon skipping in an adult-specific manner. Fn1 underwent multiple AS events that
consisted of mutually exclusive exon usage, with distinct juvenile and adult exon inclusions.
The analysis of AS events identified 1,264, 408 and 371 total ADAS events in the CC, CMs, and Heps,
respectively (Figure 1C). Among the five types of ADAS (exon skipping, intron retention, mutually exclusive
exons, 50 or 30 alternative ss), exon skipping was the most frequent (Figure 1D). There were two types of
exon skipping: juvenile- and adult-enriched exon inclusion. Adult-enriched exon inclusion was more
frequent (533 events) than juvenile-enriched exon inclusion (238 events, Figure 1E). To determine the bio-
logical relevance of ADAS, a Gene Ontology (GO) analysis was performed for the differentially spliced
genes at the juvenile and adult phases (‘‘ADAS-target genes’’). The ADAS-target genes were significantly2 iScience 23, 100929, March 27, 2020
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Figure 1. Comprehensive Identification of Age-Dependent Alternative Splicing (ADAS) in Organ Growth
(A) Schematic of the age-dependent alternative splicing (ADAS) analysis in this study. MISO, mixture of isoforms.
(B) Representative examples of ADAS events in postnatal cardiomyocytes. Numbers shown to the left of the read patterns
indicate FPKM values. Exon information was shown below.
(C) Total number of ADAS events in cerebral cortex (CC), cardiomyocytes (CMs), and hepatocytes (Heps). The alternative
splicing (AS) events were analyzed by MISO, and AS events with Bayes factors > 101/2 were counted.
(D) Numbers of each AS pattern in postnatally growing mouse organs.
(E) Frequency of juvenile- or adult-enriched specific exon inclusions. The frequency was compared between P1 and P56 or
between P7 (CMs and Heps)/P14 (CC) and P56.
See also Figure S1.associated with ‘‘nervous system development’’ and ‘‘axonogenesis’’ in the CC, ‘‘cell-cell adhesion’’ and
‘‘muscle contraction’’ in CMs, and ‘‘mitochondrial fission’’ and ‘‘extracellular exosome’’ in Heps. These
results indicate that the ADAS-target genes are engaged in the biologically relevant functions (Figure S1).
Thus, we comprehensively determined the ADAS events in postnatal growth and identified the juvenile-
specific splicing isoforms.Juvenile Expression of Srsf7
We next explored how the ADAS events were regulated. We hypothesized that juvenile-specific AS was
mediated by juvenile-specifically expressed splicing factor(s) (SFs), so we tested whether SFs were
expressed in a juvenile-specific manner. We investigated 59 SFs that were curated manually (Giulietti
et al., 2013). Unexpectedly, most of the SF genes were expressedmore highly in juvenile tissues throughoutiScience 23, 100929, March 27, 2020 3
the CC, CMs, and Heps, suggesting their functional relevance in juveniles (Figure S2). Among the juvenile-
expressed SFs, we narrowed down the candidate genes for functional analyses by choosing those with
robust and at least 2-fold higher expression than in adult in the three tissues. Among the seven genes,
Ybx1, hnRNPA0, hnRNPA1, hnRNPDL, Sfpq, Srsf2, and Srsf7, we focused on Srsf7with a relatively unknown
biological function. We will analyze the remaining six genes in a future work. Srsf7 exhibited prominent
juvenile-specific expression with high expression levels in juveniles in all three cell types (Figure 2A). This
juvenile-predominant expression was validated with quantitative PCR (Figure 2B). Our previous analysis
revealed that Srsf7 was suppressed in cellular juvenescence loss induced by depletion of the JALNC
Gm14230 (Tano et al., 2019). Immunocytochemistry revealed that Srsf7 was localized predominantly to
the nucleoplasm in Neuro2a mouse neuroblastoma cells at a lower cell density (Figures 2C and 2D). At a
higher cell density, Srsf7 expression was suppressed (Figures 2C and 2D). This cell-density-dependent
expression suggests a role for Srsf7 in the regulation of cellular growth.
We next asked whether Srsf7 expression depends on cellular juvenescence. Zeocin, a genotoxic agent,
induces loss of cellular juvenescence in NIH3T3 cells (Tano et al., 2019). We applied this method to Neuro2a
cells and observed highly efficient induction of cellular senescence, as indicated by senescence-associated
b-galactosidase (SA-b-gal) activity and extension of the cytoplasm (Serrano et al., 1997) (Figures 2E and 2F).
Srsf7 expression was significantly suppressed in the senescent cells (Figures 2G and 2H), and this result was
corroborated by western blot analysis (Figures 2I and S2B). We also analyzed the juvenescence-dependent
expression of Srsf7 in another model for cellular senescence. Cellular senescence can be induced by onco-
genic genes such as Ras (Serrano et al., 1997), BRAF (Wajapeyee et al., 2008), Akt (Chen et al., 2005), and
E2F (Denchi et al., 2005). The forced expression of RasV12 by doxycycline-inducible manner provoked
cellular senescence, which was evidenced by changes in cell morphology and impaired cell growth (Figures
S2C). The RasV12-induced cellular senescence was accompanied by suppression of Srsf7 and enhancement
of proteins associated with cellular senescence (Figures S2C–S2E). Thus, Srsf7 is more highly expressed in
juvenile organs and juvenescent cells.Depletion of Srsf7 Causes Loss of Cellular Juvenescence and Metabolic Dysfunction
To study the role of Srsf7 in cellular juvenescence, we tested the influence of Srsf7 depletion in Neuro2a
cells. siRNA-mediated knockdown of Srsf7 (Figure 3A) significantly suppressed cell growth (Figures 3B
and 3C), indicating that Srsf7 was essential for cell growth. The Srsf7-depleted cells were refractory to
retinoic acid-induced neural differentiation, indicating that the Srsf7-depleted cells lost their ability
to differentiate (Figure 3D). The earlier findings that Srsf7 was expressed in juvenile cells prompted us to
test whether Srsf7 is required for cellular juvenescence. Srsf7 knockdown led to a profound increase in
positive staining in an SA-b-gal assay (Figures 3E and 3F) and the expression of the senescence-associated
proteins p16, p27, and gH2ax (Figures 3G and S3A). These results indicate that Srsf7 is essential for cellular
juvenescence. We next assessed a role for Srsf7 in counteracting the cellular senescence. The Neuro2a-
RasV12 cells were transfected with Srsf7 or control empty plasmid, followed by doxycycline treatment to
induce the cellular senescence. The forced expression of Srsf7 suppressed the morphological changes
of the cells, in comparison with the control plasmid-transfected cells (Figures S3B and S3C).
To analyze the mechanism of growth regulation by Srsf7, we assessed the expression of metabolism-associated
proteins. Srsf7 depletion caused decreased phosphorylation of the ribosomal protein S6 (Ser240/244), suggest-
ing impaired protein synthesis (Figure 3G). Additionally, Srsf7 knockdown induced form II of Lc3, a hallmark of
autophagy, suggesting that Srsf7 depletion caused energy starvation. The findings implied that Srsf7 is required
for cell anabolism. To assess themetabolic functionof Srsf7,wemeasuredcellularmetabolismwith a flux analyzer
and revealed that Srsf7 depletion led to a decreased oxygen consumption rate (OCR, Figure 3H) with minor ef-
fects on extracellular acidification rate (ECAR Figure 3I), suggesting that mitochondrial function was impaired.
Analysis of the OCR to ECAR ratio showed Srsf7 depletion compromised oxidative phosphorylation (Figure 3J),
causing a shift to glycolysis (Figure 3K).We next addressed how the Srsf7 depletion led to themetabolic shift to-
ward the compromised oxidative phosphorylation. We first assessed mitochondrial quantity by measuring the
amountofmitochondrialgenomeDNA.Thisanalysisdidnot showasignificantchange in themitochondrialquan-
tityuponSrsf7depletion (FigureS3D). TheexpressionofmitochondrialproteinCox1didnotalterapparently (Fig-
ure 3G). To investigate the potential mechanism behind the metabolic shift, we established Srsf7-knockout (KO)
Neuro2a cell lines via CRISPR technology and performed transcriptome analysis. The RNA-seq analysis revealed
upregulation of pyruvate dehydrogenase kinase (Pdk1) and Pdk2 in the Srsf7-KO cells. These findings were vali-
dated via qPCR (Figure S3E). Pdk proteins direct the metabolic flow from the oxidative phosphorylation to4 iScience 23, 100929, March 27, 2020
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Figure 2. Srsf7 Is Expressed in Juvenile Organs and Juvenescent Cells
(A) IGV views of Srsf7 expression in the cerebral cortex (CC), cardiomyocytes (CMs), and hepatocytes (Heps) at juvenile phase postnatal day 1 (P1), P7 (CMs
and Heps), or P14 (CC) and adult phase P56. Numbers next to the read patterns (0, 100, and 600) indicate FPKM values.
(B) qPCR analysis of Srsf7 mRNA expression in CC, CMs, and Heps. Data were normalized to Polr2a.
(C) Immunofluorescent analysis of Srsf7 and Vimentin in Neuro2a cells at low and high densities. Scale bar, 50 mm.
(D) Frequency of Srsf7-expressing cells among total cells. *** p < 0.001. n = 266 and 243 cells. Data are the means G standard deviations from three
independent experiments.
(E) Staining of senescence-associated b-galactosidase (SA-b-gal) activity in cells treated with zeocin at 80 mg/mL for 96 h. Scale bar, 50 mm.
(F) Frequency of cells positive for SA-b-gal staining. *** p < 0.001. n = 365 and 158 cells. Data are the meansG standard deviations from three independent
experiments.
(G) Immunofluorescent analysis of Srsf7 in Neuro2a cells with or without zeocin treatment. Scale bar, 50 mm.
(H) Frequency of Srsf7-expressing cells among total cells. *** p < 0.001. n = 465 and 291 cells. Data are the means G standard deviations from three
independent experiments.
(I) Western blot analysis with Neuro2a cells treated with zeocin. The senescence marker proteins gH2ax and p16 were increased in zeocin-treated cells. Actb
was used as a loading control.
*p < 0.05 and ***p < 0.001, Student’s t test. Data are represented as the means G standard deviations. See also Figure S2.glycolysis (Kimet al., 2006; Kluza et al., 2012; Konet al., 2017). The enhancement of Pdk1was also observed at the
protein level in the cells depleted for Srsf7 (Figure 3G). Together, Srsf7 depletion causes the glycolysis-predom-
inant state that is accompaniedwith the upregulationof Pdk. Thus, Srsf7 is essential for cellular juvenescence and
mediates cellular anabolism.iScience 23, 100929, March 27, 2020 5
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Figure 3. Srsf7 Is Essential for Cellular Juvenescence
(A) Srsf7 knockdown efficiency was analyzed by qPCR of Srsf7 in Neuro2a cells 48 h after transfection with control siRNA or
Srsf7 siRNA. Data were normalized to Actb.
(B) Appearance of Neuro2a cells 72 h after transfection with control siRNA or Srsf7 siRNA. Scale bar, 100 mm.
(C) Number of cells per field 72 h after transfection with control siRNA or Srsf7 siRNA.
(D) Appearance of Neuro2a cells treated with 20 mM retinoic acid for 48 h to induce neural differentiation. Srsf7-depleted
cells were refractory to differentiation induction. Scale bar, 100 mm.
(E) Staining of senescence-associated b-galactosidase (SA-b-gal) activity in Neuro2a cells 72 h after transfection with
control siRNA or Srsf7 siRNA. Scale bar, 100 mm.
(F) Frequency of cells positive for SA-b-gal staining among total cells. *** p < 0.001. n = 147 and 184 cells. Data are the
means G standard deviations from three independent experiments.
(G) Western blot analysis with Neuro2 cells 72 h after transfection of control siRNA or Srsf7 siRNA. The senescence marker
proteins p16, p27, and gH2ax were increased in Srsf7-depleted cells. Tubulin was used as a loading control.
(H–K) Analysis of cell metabolism with a flux analyzer in Neuro2a cells 48 h after transfection of control siRNA or Srsf7
siRNA. (H) Oxygen consumption rate (OCR) and (I) extracellular acidification rate (ECAR) were measured at baseline and
6 iScience 23, 100929, March 27, 2020
Figure 3. Continued
under stress conditions in which cells were treated with oligomycin and FCCP. (J) OCR to ECAR ratio at the baseline
and stress conditions. (K) Energy phenotype profile of the cells transfected with control siRNA or Srsf7 siRNA.
* p < 0.05, ** p < 0.01, and *** p < 0.001, Student’s t test. Data are represented as the meansG standard deviations. See
also Figure S3.Srsf7 Regulates Growth and JAGs in Mice
To assess the role of Srsf7 in ADAS in mice, we sought to analyze Srsf7-knockout (KO) mice. Using CRISPR-
Cas9 genome editing (Cong et al., 2013; Inui et al., 2015; Mali et al., 2013), we designed a guide RNA that
introduced a double-strand break in the proximal region downstream of the initiating codon in Srsf7 (Fig-
ure S4A). This break resulted in an indel that caused a frameshift (fs) mutation (Figure S4B). Analysis of new-
borns revealed that none had homozygous mutations, implying that the null mutation caused embryonic
lethality. Analysis of fetuses at embryonic day 7.5 (E7.5) revealed that 18 fetuses (27.6%) were wild-type
(WT, Srsf7WT/WT), 30 (46.1%) were heterozygous mutants (Srsf7WT/fs), and 17 (26.1%) were absorbed
embryos, hampering the determination of a genotype (Figure S4C). The absence of a viable homozygous
mutant at E7.5 suggested early embryonic lethality. KO of Srsf3 (also known as SRp20), a gene that encodes
the SF with the closest similarity to Srsf7 (Blanco and Bernabe´u, 2012; Cavaloc et al., 1999), causes develop-
mental failure at the blastocyst stage (Jumaa et al., 1999).We therefore analyzedwhether Srsf7-null embryos
had defects at the blastocyst stage. In vitro fertilization was performed with Srsf7 heterozygous mutant
sperm and ova to analyze development into morulae and blastocysts. Srsf7-homozygous KO embryos
(Srsf7fs/fs) successfully developed into blastocysts, clarifying that the embryonic lethality of Srsf7-KO mice
occurred after the blastocyst stage and during the implantation stage (Figures S4D–S4F). Taken together,
these results show that Srsf7 is indispensable for the implantation stage of mouse development.
The embryonic lethality hampered the analysis of homozygous KOmice. Heterozygous Srsf7-KOmice were
viable and fertile, but they exhibited impaired body growth. Both male and female Srsf7WT/fs mice
exhibited lower body weight than the WT controls (Figures 4A and 4B), indicating that Srsf7 is necessary
for body growth in mice. The significant difference of body weight was observed also in the neonatal phase
(Figure S5A). To gain an insight into a role for Srsf7 in the protein synthesis in vivo, we investigated the
expression of proteins associated with the activity of the protein synthesis. The expression of phosphory-
lated S6 and phosphorylated 4E-BP1 was suppressed in the Srsf7 mutant tissues (Figures S5B and S5C).
These findings implied that Srsf7 might play a role in the regulation of protein synthesis also in vivo. To
assess the machinery underlying the growth impairment of Srsf7 mutant mice, we compared the gene
expression profiles of WT and Srsf7 mutants via RNA-seq (Figure 4C).
Heatmap analysis revealed that a subset of genes (1,716 genes) was suppressed by the Srsf7 mutation
throughout the CC, CMs, and Heps (Figure 4D). The subset included numerous JAGs and translation-asso-
ciated genes (Figure 4D). The GO analysis revealed that this gene subset was associated with ‘‘translation’’
(p < 1033) and ‘‘ribosome’’ (p < 1039) (Figure 4E). These findings suggested that translation was dysregu-
lated in the Srsf7mutant mice. Additionally, the Srsf7mutation showed a significantly more profound effect
on the JAGs than on constitutively expressed genes, demonstrating that Srsf7 is indispensable for the
expression of JAGs (Figure 4F). Among the JAGs, the expression of Igf2 was suppressed significantly in
CMs and Heps (Figure S5D). Igf2 encodes a peptide that functions as a potent enhancer of body growth
(DeChiara et al., 1990; Sun et al., 1997). The Igf2 suppression was observed also at the protein level in
Srsf7mutant hearts and livers (Figure S5E). We also addressed physiological consequences of the aberrant
ADAS in the Srsf7mutant mice. The GO analysis in the Srsf7mutant CC revealed that genes associated with
myelination were affected significantly (Figures S6A), revealing the downregulation of myelin sheath-asso-
ciated genes (Figure S6B). Immunostaining of myelin basic protein (MBP) revealed poorer myelination in
the Srsf7mutant compared withWT (Figures S6C and S6D), whereas the neuronal formation was unaffected
(Figures S6E and S6F). Thus, the Srsf7mutant mice showed the slight impairment of myelination in the CC.
Together, the Srsf7mutation causes physiological deteriorations in the body growth andmyelination that is
accompanied by compromised expression of genes associated with translation and JAGs in mice.Srsf7 Mediates ADAS
Wenext evaluatedADAS in the Srsf7mutantmice.MISO analysis revealed significantly (Bayes factor > 101/2) and
recurrently altered AS events in the Srsf7 mutant mice (Figure 5A). The cutoff we used for determining true AS
events almost completely excluded background or ‘‘noise’’ AS events, as shown by the fact that comparisonsiScience 23, 100929, March 27, 2020 7
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Figure 4. Srsf7 Regulates Growth and JAGs in Mice
(A) Thebodyweights ofWTand Srsf7-heterozygousmutantmice (numbers ofmice analyzed:WTmale, 12;mutantmale, 19;WT female, 17;mutant female, 14).
(B) Appearances of WT and Srsf7 mutant mice at age 2 weeks.
(C) A schematic describing the RNA-seq analysis with CC, CMs, and Heps isolated from WT and Srsf7 mutant mice. Two Srsf7 mutant mice and one WT
littermate control were subjected to the RNA-seq analysis.
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Figure 4. Continued
(D) Heatmap analysis of the RNA-seq results in CC, CMs, and Heps ofWT and Srsf7mutant mice. The cluster of genes with a tendency to be downregulated in
the three organs is magnified to the right. A partial list of JAGs and translation-associated genes included in the cluster is shown.
(E) Gene Ontology (GO) analysis of the Srsf7mutant-suppressed cluster. The biological processes and Kyoto Encyclopedia of Genes and Genomes (KEGG)
pathways significantly associated with the cluster are shown.
(F) Frequencies of juvenility-associated genes (JAGs) and constitutively expressed genes among the Srsf7WT/fs-suppressed genes. The Srsf7mutation affects
JAGs more strongly than constitutively expressed genes.
* p < 0.05 and *** p < 0.001, Student’s t test. Data are represented as the means G standard deviations. See also Figures S4–S6.among WT mice showed few AS events (‘‘Background AS events’’ in Figure 5A). We performed GO analysis to
predict thebiological functions associatedwith themis-splicedgenes, and the results showed that, in addition to
the expected ‘‘alternative splicing’’ (10153) (Figure 5B), functions such as ‘‘phosphoprotein’’ (10110) and
‘‘acetylation’’ (1046) were highly significantly enriched. These findings indicate that Srsf7 exerts its influence
through these enriched functions. We next asked whether Srsf7 mediated the ADAS that was observed earlier
in this study. We investigated an overlap between the ADAS-target genes and the genes undergoing Srsf7-
dependent AS. Overlaps of 33.1%, 41.8%, and 43.5% were observed between the ADAS-target genes and
Srsf7-spliced genes in the CC, CMs, and Heps with statistical significance of 2 3 10102, 3 3 1091, and 8 3
1071, respectively (Figure 5C). These observations indicate that Srsf7 mediates a considerable portion of
ADAS, thus establishing a role for Srsf7 in the age-dependent transition of the transcriptome.
Srsf7 Mediates ADAS in Eif4a2 and Rbm7
We next sought to describe Srsf7-mediated ADAS in a gene-specific manner. We focused on the Eif4a2 and
Rbm7 mRNAs, which underwent Srsf7-dependent AS at high significance (Bayes factor > 101/2). Eif4a2
underwent ADAS in which exon 11 (E11) was included in the juvenile form and excluded from the adult
form throughout the CC, CMs, and Heps (Figure 6A). Because of a premature stop codon in E11, the juve-
nile form was shortened and lacked one-third of the C-terminal RNA helicase domain (Figure 6B), losing
two beta-strands and two alpha-helixes of the RNA helicase domain compared with the adult form (Fig-
ure S5). However, E11 was skipped in Srsf7 mutant organs even in juveniles, leading to the expression of
the adult form of Eif4a2 (Figure 6C). This finding was corroborated by qPCR, which distinguishably
measured the two isoforms (Figure 6D).
Rbm7, a gene encoding an RBP associated with snoRNA biogenesis, underwent ADAS in which E2 was
included in the juvenile form and excluded from the adult form throughout the CC, CMs, and Heps (Fig-
ure 6E). Because of a stop codon in E2, the juvenile form of Rbm7 has an open reading frame of 39 amino
acids (aa) in length, which is considerably shorter than the adult form, which consists of 265 aa (Figure 6F).
Exon 2 was skipped in Srsf7 mutant organs even in juveniles, thus yielding the adult form (Figure 6G). This
finding was corroborated by qPCR (Figure 6H). Thus, our analysis revealed that Srsf7 mediates the ADAS of
Eif4a2 and Rbm7, causing switching from juvenile to adult isoforms.
Srsf7 Is Responsible for ADAS and Establishes the Juvenile Transcriptome
To assess the regulation of AS by Srsf7 more directly, we established an in vitro experimental platform for
the analysis of Srsf7-mediated AS. We cloned the genomic sequences of Eif4a2 and Rbm7 and constructed
minigene plasmids. The AS of Eif4a2 and Rbm7 were assessed in the Srsf7-KO Neuro2a cell lines (Fig-
ure 7A). The minigene assays revealed that Srsf7-KO causes the switching of isoforms from juvenile to adult
for both Eif4a2 (Figure 7B) and Rbm7 (Figure 7C). Furthermore, RNA immunoprecipitation (RIP)-qPCR
analysis revealed the binding of Srsf7 protein to the Eif4a2 RNA and Rbm7 RNA (Figure 7D). These findings
indicate that the Srsf7 protein directly mediates the AS of Eif4a2 and Rbm7.
Thus, Srsf7 mediates the ADAS of the numerous transcripts including Eif4a2 and Rbm7. The influences of
Srsf7mutation was observed for the splicing of the significant number of genes that were also regulated by
ADAS. ADAS enables higher anabolic potentials in juvenile animals through enhancing JAGs and transla-
tion-associated genes.
DISCUSSION
The age dependency of AS has not been well elucidated, and implications of ADAS for physiology and
pathogenesis remain obscure. Here, we present a comprehensive view of ADAS during postnatal growth
in a mouse model. Srsf7 mediates the ADAS of numerous genes including Eif4a2 and Rbm7. Srsf7iScience 23, 100929, March 27, 2020 9
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Figure 5. Srsf7 Mediates ADAS in Mice
(A) Number of AS events detected in Srsf7 mutant mice in comparison with WT mice (right half, ‘‘Mis-splicing events in
Srsf7 mutants’’). Comparisons were also made between WT mice to show the background noise levels (left half,
‘‘Background AS events’’).
(B) Gene Ontology (GO) analysis of the genes that were mis-spliced in Srsf7mutant mice. ‘‘Up keywords’’ and ‘‘Biological
processes’’ significantly associated with the mis-spliced genes are indicated.
(C) Venn diagrams to show overlaps between the ADAS-target genes and the genes mis-spliced in the Srsf7 mutant.contributes to the establishment of the juvenile transcriptome, which is characterized by the expression of
JAGs and translation-associated genes, thus underlying the anabolic status of juvenile animals (Figure 7E).
Although AS has been investigated in terms of tissue- or cell-type specificity, its age dependency has not
been comprehensively studied. The juvenile phase is characterized by distinct physiological features, such
as growth and maturation, and by distinct gene expression profiles enriched in JAGs (Jam et al., 2018). This
ADAS analysis revealed a previously undefined landscape of AS events, unmasking the regulatory layer of
gene expression underlying the postnatal growth phase. Our findings indicate that the postnatal growth
phase is underlain by splicing-based modifications of the transcriptome, which account for the anabolic
status of juvenile animals and the expression of JAGs and translation-associated genes, thus contributing
to juvenile properties.10 iScience 23, 100929, March 27, 2020
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Figure 6. Srsf7 Mediates ADAS of Eif4a2 and Rbm7
(A) Eif4a2 mRNA expression pattern in the juvenile and adult phases. Exon 11 (E11) is predominantly included in the
juvenile phase compared with the adult phase.
(B) Schematic of the splicing isoforms of Eif4a2. E11 is included in the juvenile isoform and not in the adult isoform. E11
contains the alternative stop codon, thus generating a shorter protein.
(C) Eif4a2mRNA expression patterns in WT and Srsf7mutant organs. E11 is included in WT but not in Srsf7mutants. The
Srsf7 mutants thus express the adult form despite the mice being juvenile.
(D) qPCR analysis of the Eif4a2 juvenile and adult isoforms in WT and Srsf7 mutant mouse tissues (n = 3). Data were
normalized to Tubb5.
(E) Rbm7 mRNA expression patterns in the juvenile and adult phases. E2 is more frequently included in juveniles than in
adults.
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Figure 6. Continued
(F) Schematic of the splicing isoforms of Rbm7. E2 is included in the juvenile isoform and not in the adult isoform. E2
contains the alternative stop codon that terminates translation.
(G) Rbm7 mRNA expression pattern in WT and Srsf7 mutant organs. E2 is included in WT but not in Srsf7 mutants. The
Srsf7 mutants thus express the adult form despite the mice being juvenile.
(H) qPCR analysis of Rbm7 juvenile and adult isoforms inWT and Srsf7mutant mouse tissues (n = 3). Data were normalized
to Tubb5.
Data are represented as the means G standard deviations. See also Figure S7.Cellular juvenescence is characterized by the cellular capacities for growth, maturation, differentiation,
anabolic metabolism, and resistance to premature senescence (Tano et al., 2019). Cellular juvenescence
is lost under suppression of the JALNC Gm14230 (Tano et al., 2019). Here, we showed that Srsf7 depletion
also led to a loss of cellular juvenescence, in that cells exhibited impaired growth, differentiation, anabo-
lism, and resistance to premature senescence. As evidenced by experiments in cells and mice, Srsf7 deple-
tion led to decreased phosphorylation of S6, indicating suppressed protein synthesis. Thus, Srsf7 regulates
anabolism through protein synthesis both in vitro and in vivo.
The Srsf7 protein showed nuclear localization, consistent with a splicing function. The nuclear expression of
Srsf7 was lost at higher density, zeocin treatment, and RasV12-induced senescence. Srsf7 was not observed
to translocate out of the nucleus, suggesting that the Srsf7 protein is regulated by its expression level and
not by subcellular localization in the contexts we examined. The cell-density-dependent expression of the
Srsf7 protein implied that Srsf7 may control anabolism in response to cell density. Srsf7 expression was also
dependent on cellular juvenescence and was lost in RasV12-induced cellular senescence. The genotoxicity
of zeocin may induce cell-cycle arrest, and it may also induce loss of cellular juvenescence through the
suppression of Srsf7.
The homozygous null mutation of Srsf7 caused early embryonic lethality, indicating its essentiality in the
implantation stage. Homozygous mutations of Srsf3, the gene with the greatest similarity to Srsf7, cause
defects in blastocyst formation before the implantation stage (Jumaa et al., 1999). This discrepancy
demonstrates the non-redundant roles of Srsf3 and Srsf7 in blastocyst formation and the implantation
stage, respectively.
Although our previous study found that the postnatal growth phase was characterized by age-dependent
alteration of the transcriptome, the functional relevance of AS has not been elucidated (Jam et al., 2018).
Not only did the juvenile transcriptome undergo extensive genome-wide AS, but we also identified Srsf7
as a crucial factor for its regulation. Srsf7 mutation caused erroneous ADAS that resulted in premature loss
of JAGs and translation-associated genes. The ADAS events were ‘‘fast-forwarded,’’ and premature switching
from juvenile to adult isoforms took place. This effect was recapitulated by in vitro experiments in Neuro2a
cells with null mutations of Srsf7, where the juvenile Eif4a2 and Rbm7 isoforms were switched to the adult
isoforms prematurely.
We demonstrated that Eif4a2 and Rbm7 are direct targets of Srsf7. Srsf7 mediates the inclusion of E11 that
contains the alternative stop codon; thus, the juvenile isoform lacks the part of the RNA helicase domain
that is crucial for microRNA-mediated translational suppression. Eif4a2 is an ATP-dependent RNA helicase
(Jackson et al., 2010) that is essential for microRNA-mediated translational repression (Meijer et al., 2013).
Thus, the shortening of the RNA helicase domain is considered to cause dysregulation of microRNA-medi-
ated translational repression, leading to increased protein expression. microRNA-mediated regulation of
growth is also regulated at the level of microRNA biogenesis, which is enhanced by Hippo signaling (Mori
et al., 2014). Srsf7-mediated AS of Eif4a2 may function as a new regulatory layer of microRNA-mediated
growth control. Rbm7, together with ZCCHC8 and hMTR4, constitutes the nuclear exosome targeting
(NEXT) complex that directs a subset of RNAs, including snoRNA, toward exosomal degradation (Fan
et al., 2017; Kufel and Grzechnik, 2019; Lubas et al., 2015; Ogami et al., 2018). Srsf7 mediates the splicing
of the juvenile isoform that includes E2 and a premature stop codon, thus expressing a considerably shorter
isoform lacking a part of the RNA recognition motif. The juvenile Rbm7 isoform spares snoRNAs from
degradation, promoting the translation process.
Our findings clarified previously unreported roles for ADAS in the establishment of the juvenile transcrip-
tome and the anabolic status of juvenile animals. Our analysis suggested a more quantitative analysis for12 iScience 23, 100929, March 27, 2020
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Figure 7. Srsf7 Mediates Isoform Switching of Eif4a2 and Rbm7
(A) Western blot analysis for Srsf7 in WT and Srsf7-KO Neuro2a cell lines. Gapdh was analyzed for the loading control.
(B) Minigene assay with the Eif4a2 gene construct. The scheme above shows the plasmid constructed to express exons
10–12 (E10–E12) of mouse Eif4a2. The primers used to detect the splicing products are indicated with arrows, and the
RT-PCR results are shown below. Srsf7-KO induces switching of isoforms from juvenile to adult.
(C) Minigene assay with the Rbm7 gene construct. The scheme above shows the plasmid constructed to express E1–E3 of
mouse Rbm7. The primers used to detect the splicing products are indicated with arrows, and the RT-PCR results are
shown below. Srsf7-KO induces switching of isoforms from juvenile to adult.
(D) RIP-qPCR was performed in Neuro2a cells after UV-cross-linking followed by immunoprecipitation with the Srsf7
antibody. qPCR was performed for Eif4a2, Rbm7, and the control, Rps13. Fold enrichment was calculated by normalizing
to IgG.
(E) Schematic describing the role of Srsf7 in ADAS, thus establishing the juvenile transcriptome underlying the anabolic
state in juveniles.
* p < 0.05, Student’s t test. Data are represented as the means G standard deviations.AS. Our work implied a possibility that a particular SF may account for the splicing of a portion of a gene
transcript and plural SFs contribute to the completion of the splicing of the particular gene. Future works
that analyze the contributions of multiple SFs to the particular splicing pattern will clarify how SFs coop-
erate in the regulation of splicing. Also, in this study, we investigated the AS at the RNA level and not at
the proteomic level. Further analysis at the proteomic level will reveal a functional consequence of the
RNA splicing on the protein functions. Because AS has numerous implications in pathogenesis, further
elucidation of the AS program and the roles of Srsf7 should lead to new therapeutics for intractable dis-
eases, especially of children, in contexts where the juvenile properties and juvenile transcriptome are
considered to be compromised. Through the AS, Srsf7 mediates the anabolic functions of the cells. By
utilizing the function of Srsf7 to promote anabolism, it might be possible to enhance the growth or regen-
erative capacity of the organs, for the purpose of treating the intractable diseases without effective treat-
ments or treatment via organ transplantation.
Here, we reported a comprehensive list of ADAS events in the postnatal organs and showed that the
splicing of the significant number of ADAS-target genes is mediated by Srsf7. Srsf7 mediates juvenile pat-
terns of AS, thus giving rise to the juvenile transcriptome. Mutation of Srsf7 causes a premature switch from
the juvenile to adult isoforms of at least Eif4a2 and Rbm7 both in vitro and in vivo, resulting in suppressed
anabolism and impaired growth. Thus, the Srsf7-mediated ADAS establishes the juvenile transcriptome
that underlies juvenile properties.iScience 23, 100929, March 27, 2020 13
Limitations of the Study
 Our AS analysis was performed with a bulk of cells, not single cells. Our analysis implied that different
types of AS might occur in a single cell. Future work at the single-cell resolution will reveal how
different types of AS occur in transcripts from the same gene.
 Our analysis has not determined the comparable contribution of Srsf7 to AS among different SFs.
Plural SFs may target to the same gene locus. Future work may make it possible to quantitatively
compare the contributions of different SFs.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
DATA AND CODE AVAILABILITY
The accession numbers for the high throughput sequencing data reported in this paper are DNAData Bank
of Japan (DDBJ): DRA009510, DRA009537 and DRA009538.
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TRANSPARENT METHODS 
 
Animal experiments 
All animal experiments were approved by the institutional animal care and use committee of 
Shiga University of Medical Science. All experiments were performed in accordance with the 
relevant guidelines and regulations. 
 
Establishment of Srsf7 mutant mice 
Reagents for genome editing 
The Srsf7 mutant mouse strains were generated using CRISPR-Cas9 technology as 
described previously (Inui et al., 2015). The C57BL/6N strain was used as the background 
strain. The guide RNA (gRNA) was designed using CRISPRdirect (https://crispr.dbcls.jp/). 
The target sequence of the gRNA is shown in Table S1. The gRNA sequence was cloned 
into the gRNA cloning vector (Addgene Plasmid ID #41824). 
To assess gRNA quality, a T7 endonuclease assay was performed. The gRNA plasmid and 
hCas9 plasmid (Addgene plasmid ID #41815) were transfected into NIH3T3 cells using 
Lipofectamine 2000 transfection reagent (Thermo Fisher Scientific). Genome DNA was 
extracted using a Puregene DNA Extraction Kit (Qiagen). The genome sequence containing 
the target site was PCR-amplified with PrimeSTAR Max DNA polymerase (Takara Bio) with 
the primers shown in Table S1. After heat denaturation followed by reannealing, cleavage 
efficiency by T7 endonuclease I was assessed by agarose gel electrophoresis. 
For gRNA synthesis, the T7 RNA polymerase recognition site was attached to the gRNA 
sequence via PCR. The PCR products were purified and used as the template for in vitro 
RNA synthesis using the mMESSAGE mMACHINE T7 Transcription Kit (Life Technologies). 
The synthesized gRNA was purified using MEGAclear (Ambion). Recombinant Cas9 protein 
was purchased (GeneArt Platinum Cas9 Nuclease, Thermo Fisher Scientific, B25642). 
 
Microinjection 
Mouse zygotes were obtained via in vitro fertilization (IVF) of WT C57BL/6N gametes. gRNA 
(100 ng/ml) and Cas9 protein (30 ng/ml, TrueCut Cas9 Protein v2, Invitrogen) were mixed 
and microinjected into the pro-nuclei and cytoplasm of zygotes, and the injected embryos 
were incubated at 37°C until they were transferred into pseudo-pregnant females at the two-
cell stage. 
 
Genotyping 
Genomic DNA was extracted from the tail tips of pups, and the genomic sequence around 
the gRNA target site was PCR-amplified using the primers shown in Table S1. The obtained 
PCR products were treated with ExoSAP-IT (Thermo Fisher Scientific) and sequenced. 
Genotype was also determined by restriction enzyme cleavage at the Afl-II site, which was 
altered by the mutations described in this study. For the analyses of Srsf7 mutant mice, both 
sexes of at least 4 different strains were analyzed. For the body weight analysis, body weight 
was measured with both sexes of mice on postnatal day 4 (P4), P7, P14 and once a week 
after 4 weeks old. 
 
In vitro fertilization, generation and culture of preimplantation embryos 
Sperm or ova were taken from sexually mature Srsf7 heterozygous mutant male or female 
mice, respectively. Female mice were superovulated by intraperitoneal administration of 0.15 
ml (7.5 IU) / animal serum gonadotropin (Serotropin, ASKA Animal Health Co., Ltd) and 0.15 
ml (7.5 IU) / animal placental gonadotropin (Gonatropin, ASKA Animal Health Co., Ltd) at the 
interval of 48 hours. HTF medium (ARK Resource) was used for IVF, and KSOM medium 
(ARK Resource) was used for embryo culture. Sperm were taken from the epididymis tail and 
resuspended in 100 μl of an HTF droplet in mineral oil (M5310, Sigma) on a 35 mm petri dish 
for 60 minutes at 37°C and 5% CO2. The ova were taken from the ampulla of the uterine tube 
16 hours after hormone administration and cultured in 200 µl of an HTP droplet in mineral oil 
on a 35 mm petri dish at 37°C and 5% CO2. Insemination was conducted by adding 4.5 μL 
precultured sperm resuspension into the ova-containing HTF droplet. Six hours after 
insemination, zygotes at the pronuclear stage were selected and transferred into 50 μl KSOM 
droplets within mineral oil and further cultured at 37°C and 5% CO2. On the next day, zygotes 
that had proceeded to the 2-cell stage were selected and further cultured until Dpc5.5. 
 
Genotyping of blastocysts with nested PCR 
To genotype the blastocysts, nested PCR was performed. Blastocysts in 2 μl of buffer were 
lysed in PCR tubes by 3 cycles of heating at 98°C and freezing at -30°C. With 1 µl of the 
lysates as a template, the 1st round of PCR was performed using PrimeSTAR Max DNA 
Polymerase (Takara Bio) (30 cycles of 10 sec at 98°C, 5 sec at 55°C and 30 sec at 72°C). 
Nested PCR was performed using 0.2% of the 1st round PCR product as a template (20 cycles 
of 10 sec at 98°C, 5 sec at 55°C and 30 sec at 72°C). The primer sequences are shown in 
Table S1. Digestion with the Afl-II restriction enzyme was used to analyse the genotypes. 
 
Cell culture 
Neuro2a (male) or NIH3T3 (male) cell lines were cultured in Eagle's Minimum Essential 
Medium (EMEM) or Dulbecco's Modified Eagle's Medium (DMEM) containing 10% fetal 
bovine serum (FBS) and penicillin/streptomycin, respectively. To induce neural differentiation, 
retinoic acid was added to the culture medium at 20μM and incubated for 48 hours. For 
zeocin-induced cellular senescence model, cells were treated with zeocin at 80μg/ml for 96 
hours. In the knockdown experiments, Lipofectamine RNAiMAX (Invitrogen) was used to 
transfect the siRNA duplexes at 10 nM: Mouse Srsf7 siRNA1 (Bioneer, AccuTarget siRNA 
ID1424257), siRNA2 (ID1424259), and siRNA negative control (Applied Biosystems, 
AM4611). The knockdown efficiency was assessed 48 hours after transfection by qPCR or 
western blot analysis. The cell images were obtained using EVOS FL (Thermo Fisher 
Scientific). The number of cells per field was counted manually.  
Inducible expression of RasV12 in Neuro2a cells 
Neuro2a cell strains that express RasV12-EGFP in the doxycycline-inducible manner were 
established by serial transfections of pcDNA6/TR and pcDNA4/TO-RasV12-EGFP. The 
plasmids were gifted by Shunsuke Kon and Yasuyuki Fujita (Hokkaido University, Japan). To 
induce RasV12-EGFP, the cell strains were treated with doxycycline at 2 μg/ml concentration 
for 96 hrs. For immunocytochemistry, cells were fixed with 4% PFA for 10 min at RT, followed 
by the membrane permeabilization with 0.1% Triton X-100 for 2 min at RT. The cells were 
then incubated with 2% FBS for blocking for 1 hr at RT. Then cells were incubated with the 
primary antibody against Srsf7 (1:200, Thermo Fisher Scientific, PA5-39482) and Vimentin 
(for the control condition, 1:80, Santa Cruz, sc-6260) for overnight at 4°C. After washing with 
PBS for 10 min 3 times, the cells were incubated with the secondary antibodies anti-rabbit-
Alexa Fluor 546 and anti-mouse-Alexa Fluor 488 (1:1,000, Invitrogen) for 1 hr at RT. The cells 
were washed and mounted with Prolong Gold with DAPI (Thermo Fisher Scientific). Images 
were taken using a confocal microscope (Leica, TCS SP8). 
To analyze the effect of Srsf7 forced expression on RasV12-induced cellular senescence, 
pcDNA4-Srsf7 or control pcDNA4 empty plasmid was transfected to the Neuro2a-RasV12 
cells, followed by the doxycycline treatment. To assess the cell shape enlargement, cells area 
were measured using Fiji (Schindelin et al., 2012). Those cells with area values >+2SD from 
the mean of the untreated control Neuro2a cells were counted as enlarged cells. 
 
CRISPR-KO of Srsf7 in Neuro2a cells 
The gRNA plasmid used for the generation of Srsf7-KO mice and hCas9 plasmid were 
transfected into Neuro2a cells using Lipofectamine 2000 transfection reagent (Thermo Fisher 
Scientific). A limiting dilution method was used to clone the cell lines. A Srsf7 genotype was 
determined by sequencing analysis. The clones that did not show any wild type sequence 
were selected and used for the analysis. The clones that did not show any mutation were 
used as WT control cell lines. 
Gene expression analysis with qPCR 
The total RNA was extracted using TRIzol reagent (Thermo Fisher Scientific). The extracted 
RNA was quantified using a NanoDrop Lite Spectrophotometer (Thermo Fisher Scientific) 
and reverse transcribed using a High-Capacity RNA-to-cDNA Kit (Applied Biosystems) and 
a PCR Thermal Cycler Dice (Takara) according to the manufacturer’s instructions. qPCR was 
performed using a LightCycler 480 SYBR Green I Master Kit on a LightCycler 480 instrument 
(Roche) using the reverse transcribed cDNA as a template. The specificity and quality of the 
qPCR amplification was assessed by confirming a single band after agarose gel 
electrophoresis and a melting curve analysis. The data were normalized to control genes as 
indicated in the Figure legends. The primers used for the qPCR were listed in Table S1.  
 
SDS-PAGE and western blot analysis 
The cells were harvested in RIPA lysis buffer containing 25 mM Tris-HCl (pH 7.6), 150 mM 
NaCl, 1% NP-40, 1% sodium deoxycholate and 0.1% SDS. Mouse tissues were crushed 
using a homogenizer (μT-12, Taitec) in RIPA buffer, and the lysates were centrifuged at 
20,400 ×g for at least 5 minutes to remove debris. Then, 5x Laemmli sample buffer was added 
to the lysates, followed by boiling at 95°C for 2 minutes (min). The protein samples (10 μg 
per lane) were separated by SDS-PAGE and transferred to a Hybond-P PVDF membrane 
(GE Healthcare). Western blotting was performed using the following antibodies: Srsf7 
(1:1000, Thermo Fisher Scientific, PA5-39482), pS6 (1:1000, Cell Signaling Technology, 
#5364), S6 (1:1000, Cell Signaling Technology, #2217), p4E-BP1 (1:1000, Cell Signaling 
Technology, #2855), Pdk1 (1:1000, Cell Signaling Technology, #3820), Cox1 (mt-Co1, 1:1000, 
Abcam, ab14705), cMyc (1:1000, Cell Signaling Technology, #5605), YAP-S127P (1:1000, 
Cell Signaling Technology, #13008), LC3B (1:1000, Cell Signaling Technology, #2775S), p16 
ARC (1:1000, Abcam, ab51243), p27 Kip1 (1:1000, Cell Signaling Technology, #3698), γH2ax 
(1:1000, Cell Signaling Technology, #9718), Igf2 (1:500, R&D Systems, MAB792-SP), 
Alpha/beta tubulin (1:1000, Cell Signaling Technology, #2148S), Gapdh (1:4000, Cell 
Signaling Technology, #5174) and beta-actin (Actb) 13E5 HRP-conjugated (1:4000, Cell 
Signaling Technology, #5125). Secondary antibodies conjugated with horseradish peroxidase 
(Thermo Fisher Scientific, anti-mouse 32430 and anti-rabbit 32460) were used at 1:1000 
dilution. The immunoreactive bands were detected using Chemi-Lumi One L or Chemi-Lumi 
One Ultra (Nacalai Tesque). 
 
Immunocytochemistry 
Neuro2a cells treated with zeocin or transfected with siRNA were fixed with 4% 
paraformaldehyde for 10 min at RT, permeabilized with 0.1% Triton X-100 for 2 min at RT, 
blocked with 2% FBS, and incubated with antibody against Srsf7 (1:200, Thermo Fisher 
Scientific, PA5-39482) and Vimentin (1:80, Santa Cruz, sc-6260) at 4°C overnight. After 
washing with PBS for 10 min 3 times, cells were incubated with anti-rabbit-Alexa Fluor 488 
and anti-mouse-Alexa Fluor 546 (1:1,000, Invitrogen) for 1 hr at RT. After washing with PBS 
for 10 min 3 times, cells were mounted with Prolong Gold with DAPI (Invitrogen). Images 
were taken using a confocal microscope (Leica, TCS SP8). 
 
Immunohistochemistry (IHC) 
Brains were dissected from WT and Srsf7 mutant mice at P7 and were fixed with 4% PFA for 
3 hrs. The tissues were embedded in OCT compound and sectioned with a cryostat at 25 μm 
thickness. The floating sections were washed with PBS and blocked in PBS containing 2% 
FBS and 0.1% Triton X-100 for 1 hr at RT. The sections were incubated in primary antibody 
against MBP (1:400, Cell Signaling Technology, 78896) or Neurofilament L (1:1000, Cell 
Signaling Technology, #2837) overnight at 4°C. After washing with PBS for 15 min 3 times, 
sections were incubated in the secondary antibody anti-rabbit-Alexa Fluor 488 (1:1,000, 
Thermo Fisher Scientific) overnight at 4°C. After washing with PBS for 15 min 3 times, 
sections were mounted on glass slides with Prolong Gold with DAPI (Invitrogen). Images 
were taken using a confocal microscope (Leica, TCS SP8). The pixel intensities were 
measured with FIJI (Schindelin et al., 2012). 
 
Flux analysis 
The oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were 
measured using an Agilent Seahorse XF Extracellular Flux Analyzer XFp (Seahorse 
Biosciences, MA). All tests were performed in accordance with the manufacturer’s 
instructions and as described previously (Solis et al., 2016). Neuro2a cells transfected with 
control siRNA or Srsf7 siRNA were seeded onto Seahorse XFp Cell Culture Miniplates 
(Seahorse Biosciences) at 12,000 cells per well and cultured for 48 hours. Before the 
metabolic analysis, cells were equilibrated in a non-CO2 incubator with Seahorse calibration 
buffer for 60 minutes. Using the Seahorse XFp Cell Energy Phenotype Test Kit (Seahorse 
Biosciences), OCR and ECAR under baseline and stressed conditions were measured and 
normalized to the number of cells at the measurement. 
 
Mitochondrial quantification 
Relative mitochondrial quantity was estimated by measuring the amount of mitochondrial 
genome DNA relative to nuclear genome DNA. The genome DNA was extracted from 
Neuro2a cells 72 hrs after transfection of control siRNA or Srsf7 siRNA (n=4) using DNeasy 
Blood and Tissue Kit (Qiagen). The quantitative real-time PCR was performed with primers 
against 16S and mt-Co1 for the mitochondrial and 18S for the nuclear genome DNA. The 
ratio of mitochondrial/nuclear genome DNA were calculated. The ratios were further 
normalized to the control siRNA condition. 
 
RNA immunoprecipitation (RIP)-qPCR 
Crosslinking was performed by exposing the Neuro2a cells in culture dishes to UV (UV 
Crosslinker, FS-800, Funakoshi) (at 254 nm and at 4000 x 100 μjoules/cm2 energy). The 
culture medium was replaced with PBS before UV-crosslinking. The cells were lysed with 
lysis buffer containing 20 mM Tris-Cl, pH 8.0, 1 mM EDTA, 100 mM NaCl, and 0.5% (v/v) 
Nonidet P-40, 0.5% sodium deoxycholate, 0.05% SDS). The cell lysates were collected by 
scraping and treated with 10 units of Turbo DNase at 37°C for 10 minutes. After centrifugation 
at 20,000 ×g for 5 minutes at 4°C, a portion (10%) of the supernatant was collected as the 
input sample. Ten micrograms of Srsf7 antibody (Thermo Fisher Scientific, #PA5-39482) and 
isotype control IgG (ab171870, Abcam) were conjugated to Dynabeads Protein A (10002D, 
Life Technologies) and incubated with the supernatants overnight at 4°C. The Dynabeads 
complexes were collected using a magnet stand (Dynal, Thermo Fisher Scientific) and 
washed with 170 µl CLIP wash buffer (1x PBS, 0.1% SDS, and 0.5% NP-40) twice for 10 
minutes and then with 170 µl high salt wash buffer (5x PBS, 0.1% SDS, and 0.5% NP-40) 
twice for 10 minutes. The beads were then resuspended in RIPA buffer (25 mM Tris-Cl, pH 
7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, and 0.1% SDS) and transferred to 
new tubes to remove nucleic acids attached to the tube walls. The crosslinks were reversed 
by incubating the beads with proteinase K at 37°C for 3 hours. The supernatant was collected 
as the RIP sample, and the RNA was extracted using TRIzol as described in the “Gene 
expression analysis” section. qPCR quantification was performed based on standard curves. 
The relative enrichment of the Srsf7 antibody was calculated by normalizing to the amount of 
RNA pulled down by the IgG control. 
 
mRNA-seq  
Cerebral cortex (CC) tissues were dissected from male mice at P1, P14 and P56 in triplicate. 
After homogenizing the tissues, total RNA was extracted with TRIzol (Invitrogen). To check 
the quality of the extracted RNA, the RNA integrity number (RIN) was determined using a 
Bioanalyzer (Agilent). The cDNA library was prepared using the TruSeq stranded mRNA 
library prep kit (Illumina). The quality of the cDNA library was checked with a Bioanalyzer and 
qPCR. The strand-specific sequencing was performed with HiSeq 2500 (read length: 50 base 
pairs, single-end; Illumina) to generate Fastq files. The RNA-seq data were processed and 
analyzed using Bio-Linux 8 (Field et al., 2006). The triplicate data of cardiomyocytes and 
hepatocytes at P1, P7 and P56 were derived from our previously deposited dataset and are 
available at accession number DRA007101 in the DDBJ Sequence Read Archive (DRA). 
To determine the juvenility-associated genes (JAGs) in the CC, the complete transcript set 
was filtered according to the following criteria: expression level higher than 0.5 fragments per 
kilobase of transcript per million fragments sequenced (FPKM) and fold change higher than 
2 at both P1 and P14 compared to P56. Gene expression was visualized using Integrative 
Genomics Viewer (http://software.broadinstitute.org/software/igv/). Gene Ontology (GO) 
analysis was performed using the Database for Annotation, Visualization and Integrated 
Discovery (DAVID) v6.8 (https://david-d.ncifcrf.gov/). 
 
Analysis of Srsf7 heterozygous mutant tissues 
Two Srsf7 mutant mice and one WT littermate control were used. CC tissues were dissected 
from Srsf7 mutant mice and a WT control littermate at P14. Cardiomyocytes and hepatocytes 
were isolated from Srsf7 mutant mice and a WT control littermate as described previously 
(Jam et al., 2018). The total RNA extracted from the cells was processed as described above 
in mRNA-seq. The strand-specific sequencing was performed with a NovaSeq 6000 (read 
length: 100 base pairs, paired-end; Illumina) to generate Fastq files. The heatmaps were 
generated using MeV (http://mev.tm4.org). 
 
Alternative splicing (AS) analysis 
The AS patterns were comprehensively analyzed using MISO (Katz et al., 2010). Reads 
obtained from the high-throughput sequencing analyses were mapped to the reference 
genome (version mm10) using HISAT (Kim et al., 2015) to generate bam files. To determine 
the age-dependent alternative splicing (ADAS) events, MISO analysis was performed with 
the bam files of the CC, CMs and Heps at P1, P7 (for CMs and Heps) / P14 (for CC) and P56, 
using “miso_annotations_mm10_v2” as the annotation. To determine the Srsf7-dependent 
AS events, MISO was used with the bam files of WT and Srsf7 mutants as the input and 
“miso_annotations_mm10_v2” as the annotation. This procedure generated results for each 
AS type: “Exon skipping (ES)”, “Intron retention (IR)”, “Mutually exclusive exons (MXE)”, 
“Alternative 5’ splice sites (A5SS)” and “Alternative 3’ splice sites (A3SS)”. To count the AS 
events, splicing events with Bayes factors higher than 101/2 were selected. For qPCR analysis, 
primers were designed to distinguish the juvenile and adult isoforms (sequences are shown 
in Table S1). 
Phyre2 (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index, Kelley et al., 2015) 
was utilized to predict the secondary and tertiary structures of Eif4a2 variants. 
 
Minigene assay 
For the minigene assays, mouse genomic sequences of Eif4a2 (containing exon 10 to 12) 
and Rbm7 (containing exon 1 to 3) were cloned into pcDNA3.1 vector. The WT control or the 
Srsf7-KO Neuro2a cells were transfected with each of the minigene plasmid and cultured for 
72 hours. Total RNA was extracted and processed for the purpose of RT-PCR analysis. The 
primer pairs used for this experiment were shown in Table S1.  
 
Statistical analysis 
For all quantified data, mean ± standard deviation (SD) is presented. Statistical significance 
between two experimental groups is indicated by an asterisk and comparisons were made 
using the Student’s t-test. P-values less than 0.05 were considered significant.   
 
Data and Code Availability 
The accession numbers for the high throughput sequencing data reported in this paper are 
DNA Data Bank of Japan (DDBJ): DRA007101, DRA009510, DRA009537 and DRA009538.  
Table S1. Sequence information. Related to Figures 2, 4, 6, 7, S3, S4 and S5.   
  
The guide RNA-target sequence Species: Mouse
Srsf7
Primers used for Srsf7 genotyping
Forward Reverse
Srsf7  genotyping PCR and
1st round of nested PCR
5'-TGAGAGTCGTTTGAGCGATG-3' 5'-ACCACCGGAGCTATATGGTG-3'
2nd round of nested PCR 5'-ACGTGTACGTTGCACAGCTC-3' 5'-CCCACTTACTTCCCATCCAA-3'
Primers used for SYBR qPCR
Gene Forward Reverse
Srsf7 5'-ATTCGCCTTTGTGGAATTTG-3' 5'-GGTGGCCTATCAAAACGAGA-3'
Igf2 5'-GCCCTCCTGGAGACATACTG-3'  5'-ACGGGGTATCTGGGGAAGT-3'
Pdk1 5'-AAATGCGAAATCACCAGGAC-3' 5'-ACCTGAATCGGGGGATAAAC-3'
Pdk2 5'-AGCTGGTGCAGAGCTGGTAT-3' 5'-GACCAGGGCATCTGTGAACT-3'
Polr2a 5'-GAGTCCAGAACGAGTGCATGA-3' 5'-ACAGGCAACACTGTGACAATC-3'
Actb 5'-CTTTGCAGCTCCTTCGTTG-3' 5'-ACGATGGAGGGGAATACAGC-3'
Tubb5 5'-GATCGGTGCTAAGTTCTGGGA-3' 5'-AGGGACATACTTGCCACCTGT-3'
Eif4a2-juvenile form 5'-GGATTGACGTGCAACAAGTG-3' 5'-AATTACGTCAACGCCGTTTC-3'
Eif4a2-adult form 5'-GGATTGACGTGCAACAAGTG-3' 5'-CCCTCTGCCAATTCTGTGAA-3'
Rbm7 -juvenile form 5'-TCCTCTTCGAGCTGTTCCAC-3' 5'-CCCAGCCTGTATGGTCAGAT-3'
Rbm7-adult form 5'-CTAGGCCTGGGACTGGAAC-3' 5'-TTACCGGCCCAGCCTGGTGG-3'
Primers used for cloning mouse Eif4a2 and Rbm7 for minigene constructs
Forward Reverse
Eif4a2_minigene_1,548bp CGGGGATGTCTAGCTTTTTG TAGGTCAGCCACATTCATGG
Rbm7_minigene_1,386bp CCTTTACGTCGTGACGTCTG AGCCAAAAACCCTCTCCCTA
Primers used for minigene assays
Gene Forward Reverse
Rbm7  minigene assay 5'-TTCTGAGGGTGCGCAGTAG-3' 5'-AGCAGATTCATGGCATAGGG-3'
Eif4a2  minigene assay 5'-TGCAACAAGTGTCCTTGGTTA-3' 5'-CCAATGCCTTTCCTCACAAG-3'
Primers used for RIP-qPCR
Gene Forward Reverse
Eif4a2 5'-TGACGAGATGGCACTCAGAA-3' 5'-CGACTCGCTCTTTATTCAAACA-3'
Rbm7 5'-TTGAGGCAGAGAGCCATATAGT-3' 5'-GAGATGCAGGCAGGAGGAC-3'
Rps13 5'-GTCCGAAAGCACCTTGAGAG-3' 5'-TTCCAATTAGGTGGGAGCAC-3'
Primers used for genome DNA quantification
Locus Forward Reverse
16S mitochondrial genome locus 5'-CCGCAAGGGAAAGATGAAAGAC-3' 5'-TCGTTTGGTTTCGGGGTTTC-3'
mt-Co1  mitochondrial genome locus 5'-GCCCCAGATATAGCATTCCC-3' 5'-GTTCATCCTGTTCCTGCTCC-3'
18S nuclear genome locus 5'-TAGAGGGACAAGTGGCGTTC-3' 5'-CGCTGAGCCAGTCAGTGT-3'
5'-GGCAATCCACACAGTTCTTAAGG-3'
